Driving Your Clinical Assets Forward
Mariliam provides end-to-end operational planning and execution for Phase I-III clinical trials across oncology, neurology, autoimmune, infectious diseases, and rare disorders. With a proven track record in global study execution, risk management, and stakeholder collaboration, we are your dedicated partner in lean biotech environments—delivering complex programs on time and within budget.
Why Choose Mariliam
Proven Track Record
Successfully led global Phase I-III trials across multiple therapeutic areas including oncology, neurology, infectious diseases, and autoimmune disorders. Delivered complex clinical programs on time and within budget in lean biotech environments.
End-to-End Expertise
From IND preparation and site selection to CRO management and regulatory submissions, we provide comprehensive operational leadership across the entire clinical development lifecycle.
Global Experience
Extensive history managing clinical trials and alliance partnerships across North America, South America, Europe, Asia-Pacific, and Africa—with direct operational experience in Japan, Cambodia, Ghana, and Liberia.
Strategic Partnership
Not just a consultant—a true operational partner. We embed with your team to drive study execution, manage risk, and ensure seamless cross-functional collaboration from protocol design through database lock.
Ready to Advance Your Clinical Program?
Let's discuss how Mariliam can accelerate your clinical development timelines while maintaining the highest standards of quality and compliance.
Schedule a Consultation